Prognosis
The disease can either be self-limited or have a lifelong chronic course, but with treatment, about 50% of patients have marked improvement in visual field function. (1)
Treatment failure is associated with high-grade papilloedema, visual acuity loss, and frequent transient visual obscurations. (2)
References
- Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010 Aug;28(3):593-617.
- Wall M, Falardeau J, Fletcher WA, et al. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology. 2015 Sep 1;85(9):799-805.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page